Enhancing early psychosis treatment using smartphone technology

A longitudinal feasibility and validity study

Tara A Niendam, Laura Tully, Ana-Maria Iosif, Divya Kumar, Kathleen E. Nye, Jennifer C. Denton, Lauren N. Zakskorn, Taylor L. Fedechko, Katherine M. Pierce

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Smartphone applications that promote symptom tracking and self-management may improve treatment of serious mental illness (SMI). Although feasibility has been established in chronic adult outpatient or inpatient SMI samples, no data exist regarding implementation of smartphone technology in adolescent and young adult populations as part of early psychosis (EP) outpatient care. We implemented a smartphone “app” plus clinician Dashboard as an add-on treatment tool in the University of California, Davis Early Psychosis Program. Participants completed daily and weekly surveys examining mood, symptoms, and treatment relevant factors via the app for up to 14 months. Clinicians discussed symptom ratings and surveys during regular treatment sessions using the Dashboard. We report methodological details of the study, feasibility metrics, and analyses of the validity of measuring symptoms via self-report using mobile health (mHealth) technology in comparison to gold-standard clinician-rated interviews based on a comprehensive longitudinal analysis of within-person data. Results demonstrate that integrating mHealth technology into EP care is feasible and self-report assessment of symptoms via smartphone provides symptom data comparable to that obtained via gold-standard clinician-rated assessments.

Original languageEnglish (US)
Pages (from-to)239-246
Number of pages8
JournalJournal of Psychiatric Research
Volume96
DOIs
StatePublished - Jan 1 2018

Fingerprint

Feasibility Studies
Psychotic Disorders
Technology
Biomedical Technology
Telemedicine
Gold
Self Report
Therapeutics
Ambulatory Care
Self Care
Inpatients
Young Adult
Outpatients
Interviews
Smartphone
Population
Surveys and Questionnaires

Keywords

  • mHealth
  • Mobile health
  • Mobile interventions
  • Relapse prevention
  • Schizophrenia

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Enhancing early psychosis treatment using smartphone technology : A longitudinal feasibility and validity study. / Niendam, Tara A; Tully, Laura; Iosif, Ana-Maria; Kumar, Divya; Nye, Kathleen E.; Denton, Jennifer C.; Zakskorn, Lauren N.; Fedechko, Taylor L.; Pierce, Katherine M.

In: Journal of Psychiatric Research, Vol. 96, 01.01.2018, p. 239-246.

Research output: Contribution to journalArticle

Niendam, Tara A ; Tully, Laura ; Iosif, Ana-Maria ; Kumar, Divya ; Nye, Kathleen E. ; Denton, Jennifer C. ; Zakskorn, Lauren N. ; Fedechko, Taylor L. ; Pierce, Katherine M. / Enhancing early psychosis treatment using smartphone technology : A longitudinal feasibility and validity study. In: Journal of Psychiatric Research. 2018 ; Vol. 96. pp. 239-246.
@article{92fa523365144e728b4638061bb49ba7,
title = "Enhancing early psychosis treatment using smartphone technology: A longitudinal feasibility and validity study",
abstract = "Smartphone applications that promote symptom tracking and self-management may improve treatment of serious mental illness (SMI). Although feasibility has been established in chronic adult outpatient or inpatient SMI samples, no data exist regarding implementation of smartphone technology in adolescent and young adult populations as part of early psychosis (EP) outpatient care. We implemented a smartphone “app” plus clinician Dashboard as an add-on treatment tool in the University of California, Davis Early Psychosis Program. Participants completed daily and weekly surveys examining mood, symptoms, and treatment relevant factors via the app for up to 14 months. Clinicians discussed symptom ratings and surveys during regular treatment sessions using the Dashboard. We report methodological details of the study, feasibility metrics, and analyses of the validity of measuring symptoms via self-report using mobile health (mHealth) technology in comparison to gold-standard clinician-rated interviews based on a comprehensive longitudinal analysis of within-person data. Results demonstrate that integrating mHealth technology into EP care is feasible and self-report assessment of symptoms via smartphone provides symptom data comparable to that obtained via gold-standard clinician-rated assessments.",
keywords = "mHealth, Mobile health, Mobile interventions, Relapse prevention, Schizophrenia",
author = "Niendam, {Tara A} and Laura Tully and Ana-Maria Iosif and Divya Kumar and Nye, {Kathleen E.} and Denton, {Jennifer C.} and Zakskorn, {Lauren N.} and Fedechko, {Taylor L.} and Pierce, {Katherine M.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.jpsychires.2017.10.017",
language = "English (US)",
volume = "96",
pages = "239--246",
journal = "Journal of Psychiatric Research",
issn = "0022-3956",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Enhancing early psychosis treatment using smartphone technology

T2 - A longitudinal feasibility and validity study

AU - Niendam, Tara A

AU - Tully, Laura

AU - Iosif, Ana-Maria

AU - Kumar, Divya

AU - Nye, Kathleen E.

AU - Denton, Jennifer C.

AU - Zakskorn, Lauren N.

AU - Fedechko, Taylor L.

AU - Pierce, Katherine M.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Smartphone applications that promote symptom tracking and self-management may improve treatment of serious mental illness (SMI). Although feasibility has been established in chronic adult outpatient or inpatient SMI samples, no data exist regarding implementation of smartphone technology in adolescent and young adult populations as part of early psychosis (EP) outpatient care. We implemented a smartphone “app” plus clinician Dashboard as an add-on treatment tool in the University of California, Davis Early Psychosis Program. Participants completed daily and weekly surveys examining mood, symptoms, and treatment relevant factors via the app for up to 14 months. Clinicians discussed symptom ratings and surveys during regular treatment sessions using the Dashboard. We report methodological details of the study, feasibility metrics, and analyses of the validity of measuring symptoms via self-report using mobile health (mHealth) technology in comparison to gold-standard clinician-rated interviews based on a comprehensive longitudinal analysis of within-person data. Results demonstrate that integrating mHealth technology into EP care is feasible and self-report assessment of symptoms via smartphone provides symptom data comparable to that obtained via gold-standard clinician-rated assessments.

AB - Smartphone applications that promote symptom tracking and self-management may improve treatment of serious mental illness (SMI). Although feasibility has been established in chronic adult outpatient or inpatient SMI samples, no data exist regarding implementation of smartphone technology in adolescent and young adult populations as part of early psychosis (EP) outpatient care. We implemented a smartphone “app” plus clinician Dashboard as an add-on treatment tool in the University of California, Davis Early Psychosis Program. Participants completed daily and weekly surveys examining mood, symptoms, and treatment relevant factors via the app for up to 14 months. Clinicians discussed symptom ratings and surveys during regular treatment sessions using the Dashboard. We report methodological details of the study, feasibility metrics, and analyses of the validity of measuring symptoms via self-report using mobile health (mHealth) technology in comparison to gold-standard clinician-rated interviews based on a comprehensive longitudinal analysis of within-person data. Results demonstrate that integrating mHealth technology into EP care is feasible and self-report assessment of symptoms via smartphone provides symptom data comparable to that obtained via gold-standard clinician-rated assessments.

KW - mHealth

KW - Mobile health

KW - Mobile interventions

KW - Relapse prevention

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=85032814700&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032814700&partnerID=8YFLogxK

U2 - 10.1016/j.jpsychires.2017.10.017

DO - 10.1016/j.jpsychires.2017.10.017

M3 - Article

VL - 96

SP - 239

EP - 246

JO - Journal of Psychiatric Research

JF - Journal of Psychiatric Research

SN - 0022-3956

ER -